153 related articles for article (PubMed ID: 33062405)
1. Identification of potential biomarkers and their clinical significance in gastric cancer using bioinformatics analysis methods.
Liu J; Zhou M; Ouyang Y; Du L; Xu L; Li H
PeerJ; 2020; 8():e9174. PubMed ID: 33062405
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
Han C; Zhang C; Wang H; Li K; Zhao L
BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
[TBL] [Abstract][Full Text] [Related]
3. Transcriptome-wide analysis of alternative mRNA splicing signature in the diagnosis and prognosis of stomach adenocarcinoma.
Shi Y; Chen Z; Gao J; Wu S; Gao H; Feng G
Oncol Rep; 2018 Oct; 40(4):2014-2022. PubMed ID: 30106437
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases.
Cheng X; Li X; Gu Y; Zhou L; Tang J; Dai X; Jiang H; Huang Y; Zhang Y; Xu T; Liu Z; Zhao Q
Med Sci Monit; 2020 Nov; 26():e925772. PubMed ID: 33219199
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatics analysis of the prognostic and immunotherapeutic significance of NPRL2 in stomach adenocarcinoma.
Pi Y; Zhan Y; Song J; Jin X; Chen J
J Gastrointest Oncol; 2022 Aug; 13(4):1589-1604. PubMed ID: 36092347
[TBL] [Abstract][Full Text] [Related]
6. ITGB1 as a prognostic biomarker correlated with immune suppression in gastric cancer.
Gu W; Sun H; Zhang M; Mo S; Tan C; Ni S; Yang Z; Wang Y; Sheng W; Wang L
Cancer Med; 2023 Jan; 12(2):1520-1531. PubMed ID: 35864742
[TBL] [Abstract][Full Text] [Related]
7. Profiles of alternative splicing in colorectal cancer and their clinical significance: A study based on large-scale sequencing data.
Xiong Y; Deng Y; Wang K; Zhou H; Zheng X; Si L; Fu Z
EBioMedicine; 2018 Oct; 36():183-195. PubMed ID: 30243491
[TBL] [Abstract][Full Text] [Related]
8. Identification of potential targets of triptolide in regulating the tumor microenvironment of stomach adenocarcinoma patients using bioinformatics.
Qiu H; Zhang X; Yu H; Gao R; Shi J; Shen T
Bioengineered; 2021 Dec; 12(1):4304-4319. PubMed ID: 34348580
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases.
He RQ; Zhou XG; Yi QY; Deng CW; Gao JM; Chen G; Wang QY
Cell Physiol Biochem; 2018; 48(3):1355-1368. PubMed ID: 30048970
[TBL] [Abstract][Full Text] [Related]
10. Characterization of alternative splicing events and prognostic signatures in gastric cancer.
Zhu N; Zhao Y; Yan W; Wei L; Sang Q; Li J; Liu B; Yu B
Cancer Cell Int; 2024 May; 24(1):167. PubMed ID: 38734676
[TBL] [Abstract][Full Text] [Related]
11. Survival-associated alternative splicing events interact with the immune microenvironment in stomach adenocarcinoma.
Ye ZS; Zheng M; Liu QY; Zeng Y; Wei SH; Wang Y; Lin ZT; Shu C; Zheng QH; Chen LC
World J Gastroenterol; 2021 Jun; 27(21):2871-2894. PubMed ID: 34135559
[TBL] [Abstract][Full Text] [Related]
12. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.
Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J
J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607
[TBL] [Abstract][Full Text] [Related]
13. The Role of Alternative Splicing Factors, DDB2-Related Ageing and DNA Damage Repair in the Progression and Prognosis of Stomach Adenocarcinoma Patients.
Wang X; Huang Z; Li L; Yang Y; Zhang J; Wang L; Yuan J; Li Y
Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672781
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Characterization of RNA Processing Factors in Gastric Cancer Identifies a Prognostic Signature for Predicting Clinical Outcomes and Therapeutic Responses.
Lou S; Meng F; Yin X; Zhang Y; Han B; Xue Y
Front Immunol; 2021; 12():719628. PubMed ID: 34413861
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of ECT2 is associated with poor prognosis in gastric cancer patients.
Jin Y; Yu Y; Shao Q; Ma Y; Zhang R; Yao H; Xu Y
Int J Clin Exp Pathol; 2014; 7(12):8724-31. PubMed ID: 25674238
[TBL] [Abstract][Full Text] [Related]
16. Identification of prognostic alternative splicing signature in gastric cancer.
Wang Z; Wu Q; Liu Y; Li Q; Li J
Arch Public Health; 2022 May; 80(1):145. PubMed ID: 35614517
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis and establishment of a prediction model of alternative splicing events reveal the prognostic predictor and immune microenvironment signatures in triple negative breast cancer.
Yu S; Hu C; Liu L; Cai L; Du X; Yu Q; Lin F; Zhao J; Zhao Y; Zhang C; Liu X; Li W
J Transl Med; 2020 Jul; 18(1):286. PubMed ID: 32723333
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of ECT2 is associated with transcriptional program of cancer stem cells and predicts poor clinical outcome in gastric cancer.
Gong DY; Chen X; Yang TL; Wang Y; Guo Y; Zeng JH; Chen SZ
Oncol Lett; 2020 Oct; 20(4):54. PubMed ID: 32788941
[TBL] [Abstract][Full Text] [Related]
19. Expression and clinical significance of
Liu H; Liu D; Li Z
J Gastrointest Oncol; 2023 Apr; 14(2):824-832. PubMed ID: 37201052
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of ECT2 Predicts Adverse Clinical Outcomes and Increases 5-Fluorouracil Resistance in Gastric Cancer Patients.
Zhang H; Geng Y; Sun C; Yu J
J Oncol; 2021; 2021():2102890. PubMed ID: 34367280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
